Washington recalls
3,471 federal recalls affecting Washington in the last 12 months - 259 Washington-specific plus 3,212 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-03-04FDA-DeviceMRIMedClass IINationwideStop using MRIMed SL-111 exam light batteries
Due to battery component overheating while charging resulting in melting of internal components and causing smoke.
- 2026-03-04FDA-DeviceMedlineClass IINationwideStop using Meijer saline wound wash spray
Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.
- 2026-03-04FDA-DeviceMedlineClass IINationwideStop using Medline Nail Kit DYKM1528
Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.
- 2026-03-04FDA-DeviceMedlineClass IINationwideStop using Medline Convenience Kits
Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.
- 2026-03-04FDA-DeviceMedlineClass IINationwideStop using Medline Convenience Nail Kit
Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.
- 2026-03-04FDA-DeviceMedlineClass IINationwideStop using Medline Sterile Saline Wound Wash
Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.
- 2026-03-04FDA-DeviceHitachiClass IICheck Hitachi Proton Beam Therapy positioning
Software anomaly in the patient positioning system may result in positional discrepancy.
- 2026-03-04FDA-DeviceHitachiClass IICheck Hitachi proton therapy system positioning
Software anomaly in the patient positioning system may result in positional discrepancy.
- 2026-03-04FDA-FoodNavitasClass INAVITAS ORGANICS ORGANIC CHIA SEEDS NET WT 8 OZ (227g) INGREDIENTS: CERTIFIED ORGANIC CHIA SEED (SALVIA HISPANICA). Product of Mexico/Argentina/Paraguay. Distributed by Navitas Organics Novato, CA USA 94949 UPC: 858847000284
Potential contamination with Salmonella.
- 2026-03-04FDA-FoodKoi Koi TradingClass IStop using Koi Koi Trading frozen fish balls
Undeclared allergen ingredient (Wheat and Sesame)
- 2026-03-04FDA-FoodKoi Koi TradingClass IStop using Koi Koi Trading frozen fish balls
Undeclared allergen ingredient (Wheat and Sesame)
- 2026-03-04FDA-FoodKoi Koi TradingClass IStop using Koi Koi Trading frozen fish balls
Undeclared allergen ingredient (Wheat and Sesame)
- 2026-03-04FDA-FoodSB FoodClass IIStop eating Yoyo Gummy Grape Plus
The products contain an unallowed color Carmoisine (E122) - Acid Red 14.
- 2026-03-04FDA-FoodSB FoodClass IIStop eating Yoyo Gummy Tropical Flavor
The products contain an unallowed color Carmoisine (E122) - Acid Red 14.
- 2026-03-04FDA-FoodSB FoodClass IIStop eating Yoyo Gummy Assorted Flavor
The products contain an unallowed color Carmoisine (E122) - Acid Red 14.
- 2026-03-04FDA-FoodOregon Potato Company LLCClass ICheck IQF blueberries for recall lot codes
Listeria monocytogenes
- 2026-03-04FDA-FoodPrime Food Processing LLC.Class IStop using Prime Food Processing dried croaker fish
Uneviscerated Fish
- 2026-03-04FDA-FoodGerber Products Company dba Nestle Infant NutritionClass IINationwideGerber Arrowroot Biscuits, Net Wt. 5.5 oz. (155g), packaged in a plastic resealable bag with UPC 015000005962, packed 4 bags/case with UPC 015000935726; Made for Gerber Products Co., Fremont, MI 49413
Downstream recall. Product contains arrowroot flour ingredient that was voluntarily recalled by the supplier due to potential contamination of soft kraft paper/plastic bag pieces.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using BioGlo Fluorescein Sodium eye strips
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using Bio Glo Fluorescein Sodium strips
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using Wizcure Fluorescein Sodium eye strips
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using Vista Gonio Eye Lubricant
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using Vista Meibo Tears eye drops
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using Vista Gel eye drops
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure PharmaClass IINationwideStop using Vista Tears eye drops
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugAgeboxClass IINationwideStop using Agebox iKids-Growth Night Formula
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
- 2026-03-04FDA-DrugAgeboxClass IINationwideStop using Agebox iKids-Growth capsules
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
- 2026-03-04FDA-DrugSlate Run PharmaceuticalsClass IIINationwideCheck Slate Run Eptifibatide Injection labeling
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
- 2026-03-04FDA-DrugAvKAREClass IINationwideStop using AvKARE Amantadine HCl capsules
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
- 2026-03-04FDA-DrugLeo PharmaClass IINationwideStop using recalled Adbry injection lots
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
Get notified about new Washington recalls
Free weekly digest. Add Washington to your profile to filter alerts to your state.
Get the Sunday Brief